Latest Medical News

  1. ]]>(MedPage Today) -- WASHINGTON -- The House voted 230-192 on Thursday, along party lines, to pass a bill championed by Democrats that aims to lower drug costs by allowing price negotiation in the Medicare program. House Democrats celebrated passage...
  2. ]]>(MedPage Today) -- Cardiovascular trials used to support current guidelines on myocardial revascularization have a robustness problem: over a quarter of these studies would have had statistically significant results rendered nonsignificant if just...
  3. ]]>(MedPage Today) -- It's hard to explain what we do. And so maybe, it's hard for others to sympathize with our situations. I mean, physicians, mid-levels, and nurses in emergency departments are tied to computers in often cramped work-spaces, even...
  4. ]]>(MedPage Today) -- SAN ANTONIO – Years after treatment had ended, women at high risk of breast cancer who were on anastrozole preventive therapy continued to be protected better than women not treated with the aromatase inhibitor, researchers...
  5. ]]>(MedPage Today) -- Sacubitril/valsartan (Entresto) is generally associated with better outcomes than other medications for heart failure with reduced ejection fraction (HFrEF) -- but perhaps not for black patients, a study showed. All-cause...
  6. ]]>(MedPage Today) -- The year in cardiology started out with a scramble to understand the December 2018 meta-analysis that showed a near doubling in mortality with paclitaxel devices for peripheral artery disease (PAD). The FDA announced it was...
  7. ]]>(MedPage Today) -- Nephrotoxic medications are prescribed at high rates to children with chronic kidney disease (CKD) by primary care physicians, potentially placing these patients at risk, said the authors of a large population-based study. About...
  8. ]]>(MedPage Today) -- ORLANDO -- Among the research at this year's American Society of Hematology (ASH) meeting, investigators presented noteworthy findings on novel agents for blood cancers, an innovative gene therapy for sickle cell disease, and...
  9. ]]>(MedPage Today) -- SAN ANTONIO -- A neoadjuvant chemo-free combination achieved similar responses to a standard chemotherapeutic regimen for postmenopausal women with high-risk luminal B breast cancer, a small randomized trial out of Spain indicated...
  10. ]]>(MedPage Today) -- WASHINGTON -- By a vote of 72-18, the Senate on Thursday confirmed Stephen Hahn, MD, as the next FDA commissioner. Hahn, 59, is the administration's choice to lead the agency in the wake of the departure of Scott Gottlieb...
  11. (MedPage Today) -- Study Authors: Jaideep Kapur, Jordan Elm, et al.; Phil E. Smith Target Audience and Goal Statement: Neurologists, critical care specialists, emergency department physicians, family physicians, primary care physicians The goal...
  12. ]]>(MedPage Today) -- Whether teprotumumab's benefits in thyroid eye disease outweigh risks for muscle spasm and worsened bowel inflammation will be voted upon at Friday's meeting of the FDA's Dermatologic and Ophthalmic Drugs Advisory Committee...
  13. (MedPage Today) -- Study Authors: Pamela L. Lutsey, Faye L. Norby, et al. Target Audience and Goal Statement: Cardiologists, hematologists, orthopedists, family physicians, primary care physicians The goal of this study was to test the hypothesis...
  14. ]]>(MedPage Today) -- At the 2019 IDWeek conference, researchers reported that some dental patients who were inappropriately given antibiotics prior to procedures suffered adverse events potentially connected to the drugs, including anaphylaxis and...
  15. ]]>(MedPage Today) -- Since its approval for patients with multiple myeloma in early 2018, uptake of denosumab (Xgeva) has been rapid, with a new study reporting the drug now reaching almost 40% of the bone-modifying market for this disease. Of 15...